Mike Injaychock joined Arcutis in February 2025 as vice president commercial operations and is responsible for driving data-driven strategies, optimizing commercial operations, and ensuring actionable insights across the organization. Prior to joining Arcutis, Mr Injaychock spent three years at Aurinia Pharmaceuticals as vice president commercial operations, where he accelerated the launch of their lead asset and built out several strategic capabilities within the commercial organization. He also spent four years at Celgene (Bristol-Myers Squibb post-acquisition) as executive director commercial operations and analytics and executive director CAR-T commercialization. In these roles, he provided strategic leadership to multiple brand and field teams, resulting in five successful launches in hematology/oncology. Mr Injaychock began his career at Eli Lilly, where over 10 years, he held roles of increasing responsibilities across sales, marketing, and operations, including a three-year expatriate assignment. Mr Injaychock received a BA from William & Mary and an MBA from UNC Kenan-Flagler Business School.
Download our corporate fact sheet.
Download